Feasibility of a new electronic patient-reported outcome (ePRO) system for an advanced therapy clinical trial in immune-mediated inflammatory disease (PROmics): protocol for a qualitative feasibility study

Search results

• Finished

  Patient-reported outcomes assessment to support accelerated access to advanced cell and gene therapies:PROmics

  Calvert, M. (Principal Investigator), Newsome, P. (Co-Investigator), Kyte, D. (Co-Investigator), Harding, R. (Co-Investigator) & Rowe, A. (Co-Investigator)

  TECHNOLOGY STRATEGY BOARD

  1/12/18 → 31/03/22

  Project: Other Government Departments

  • Electronic Patient-reported Outcome (ePRO) 100%
  • Patient-Reported Outcome 100%
  • Advanced Therapy Medicinal Products 87%
  • Basket Trial 62%
  • Cell Therapy 57%

• Midland & Wales Advanced Therapy Treatment Centre (ATTC)

  Newsome, P. (Principal Investigator), Ghosh, S. (Co-Investigator), Craddock, C. (Co-Investigator), Calvert, M. (Co-Investigator) & Filer, A. (Co-Investigator)

  TECHNOLOGY STRATEGY BOARD

  1/03/18 → 31/03/22

  Project: Other Government Departments

  • Cell Therapy 100%
  • Electronic Patient-reported Outcome (ePRO) 93%
  • Systematic Review 93%
  • Patient-Reported Outcome 93%
  • Advanced Therapy Medicinal Products 81%